key: cord-0732654-u8m0tt3b
authors: Romaguera, Rafael; Ribera, Aida; Güell-Viaplana, Francesc; Tomás-Querol, Carlos; Muñoz-Camacho, Juan Francisco; Agudelo, Víctor
title: Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic
date: 2020-06-05
journal: Rev Esp Cardiol (Engl Ed)
DOI: 10.1016/j.rec.2020.06.001
sha: ef48fe3a9ee400b3fcad9d60641d74a839dc69a7
doc_id: 732654
cord_uid: u8m0tt3b

nan

1

Cataluña durante la pandemia de COVID-19

To the Editor, On February 2020, the coronavirus disease of 2019 (COVID-19) rapidly spread throughout Europe.

Due to the lack of pharmacological treatment or vaccine, governments adopted measures called social distancing to reduce the peak intensity of the epidemic. In Spain, the government issued a decree declaring a state of alarm on 14 March, 2020.

Timely reperfusion therapy by primary percutaneous coronary intervention (pPCI) is recommended for patients with ST-segment elevation myocardial infarction (STEMI) 1 and its benefit is time-dependent, with longer delays associated with worse outcomes. A recent survey of Spanish STEMI networks reported a reduction in pPCI procedures during the COVID-19 pandemic. 2 We aimed to assess the reduction in STEMI admissions and changes in patient characteristics, delay times and early mortality during the first weeks of the COVID-19 pandemic in Catalonia.

In Catalonia, a Spanish region with 7.6 million inhabitants, acute care for patients with STEMI is organized through a regional network of 10 pPCI hospitals.

The AMI code registry collects data from all attended STEMI patients. The registry belongs to the health department of the Catalan government and its completion is compulsory and periodically audited. The database conforms to ethical and legal requirements for research purposes, and all study procedures are conducted in accordance with the ethical standards of the Helsinki Declaration.

All patients with a confirmed STEMI from 1 March to 19 April, 2020, were compared with patients attended within the same dates in 2019. A total of 395 STEMI patients were admitted during the 2020 period and 524 during the same period in 2019. The mean number of daily admissions was 10.5 in 2019 and 7.9 in 2020 (incidence rate ratio, 0.75; 95% confidence interval, 0.66-0.86). In 2020, there was a significant 52% reduction in daily admissions from day 1 to day 50 (figure 1). There were few differences between the groups (table 1) .

A similar reduction in STEMI admissions has already been reported in other settings. [3] [4] [5] To our knowledge, this is the first study performed in Spain using individual patient data from a regional STEMI network. We observed a 50% reduction in STEMI admissions in 50 days and only slight differences in patient characteristics and delay times compared with patients admitted during the same period in 2019. Potential causes of this decrease in STEMI admissions include avoidance of medical care due to social distancing, STEMI underdiagnosis, and competing risk with the acquisition and severity of COVID-19, and warrant further investigation. 

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Impact of the COVID-19 pandemic on interventional cardiology activity in Spain

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ Cardiovasc Qual Outcomes

Reduced Rate of Hospital Admissions for ACS during

Covid-19 Outbreak in Northern Italy

Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic